1-13 of 13
Xia Mao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Proteomics and Single-Cell Transcriptomics Reveal Differentiation Patterns of pDC-like LSCs and Poor Prognosis in AML with pDC Expansion

Free
Xingcheng Yang, Juan Peng, Lei Zhang, Yicheng Zhang, Xia Mao, Jue Wang, Jia Wei
Journal: Blood
Blood (2024) 144 (Supplement 1): 2935.
https://doi.org/10.1182/blood-2024-202707
Published: 2024
Journal Articles

Prognostic and Therapeutic Implications of Early Assessment in AML and MDS Patients Treated with Selinexor-Containing Chemotherapy-Free Regimen

Free
Su Shuai, Bin Xu, Xiwen Tong, Yi Zhu, Shiyuan Zhang, Xia Mao, Zhiqiong Wang, Min Xiao, Donghua Zhang, Jia Wei
Journal: Blood
Blood (2024) 144 (Supplement 1): 6004.
https://doi.org/10.1182/blood-2024-205664
Published: 2024
Journal Articles

Selinexor-Based Chemotherapy-Free or Low-Dose Chemotherapy Regimens in Acute Myeloid Leukemia, Myelodysplastic Syndromes: Efficacy and Safety

Free
Xiwen Tong, Bin Xu, Su Shuai, Yi Zhu, Jin Jie, Yizhou Peng, Li Li, Mengyuan Li, Xia Mao, Wei Huang, Donghua Zhang, Jia Wei
Journal: Blood
Blood (2024) 144 (Supplement 1): 6003.
https://doi.org/10.1182/blood-2024-205493
Published: 2024
Journal Articles

Selinexor in Combination with Standard or Reduced-Dose Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Multiple Myeloma

Free
Su Shuai, Bin Xu, Chunrui Li, Di Wang, Xiwen Tong, Yi Zhu, Xia Mao, Min Xiao, Donghua Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7062.
https://doi.org/10.1182/blood-2024-204278
Published: 2024
Journal Articles

Impact of Selinexor on AML Cell Lines and Healthy Donor T Cell Function: Enhanced Treg Cell Proportion

Free
Xiwen Tong, Xiaojian Zhu, Su Shuai, Yi Zhu, Bin Xu, Yizhou Peng, Shiyuan Zhang, Jin Jie, Xia Mao, Jia Wei, Donghua Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 5817.
https://doi.org/10.1182/blood-2024-205174
Published: 2024
Journal Articles

Real-World Experience with Selinexor -Containing Regimens in Post-Transplant AML/MDS Patients Who MRD Still Positive after First-Line Preemptive Treatment

Free
Xiwen Tong, Shuai Su, Bin Xu, Xiaojian Zhu, Yizhou Peng, Jin Jie, Xia Mao, Min Xiao, Jay Mei, Donghua Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5837.
https://doi.org/10.1182/blood-2023-186006
Published: 2023
Journal Articles

Heterogeneity and Differentiation Patterns of pDC Cells in pDC-AML: A Novel Perspective from Single-Cell RNA Sequencing

Free
Xingcheng Yang, Juan Peng, Chunrui Li, Yicheng Zhang, Xia Mao, Jue Wang, Jia Wei
Journal: Blood
Blood (2023) 142 (Supplement 1): 1568.
https://doi.org/10.1182/blood-2023-190826
Published: 2023
Journal Articles

Phase 1 Dose Escalation Study of the Anti-CD7 CAR-T Therapy in Relapsed/Refractory T-Cell Acute Leukemia and Lymphoblastic Lymphoma

Free
Jiali Cheng, Jue Wang, Xia Mao, Wei Mu, Shijia Sun, Xiaoxi Zhou, Liang Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6863.
https://doi.org/10.1182/blood-2023-184370
Published: 2023
Journal Articles

Patterns of CS1 Expression on Natural Killer Cells and Correlated Factors in Plasma Cell Dyscrasias

Free
Chunrui Li, Di Wang, Chunhui Li, Yanjie Xu, Xia Mao, Yimei Que, Zhe Li, Qiuxia Yu, Ning An, Xiaolu Long
Journal: Blood
Blood (2023) 142 (Supplement 1): 6686.
https://doi.org/10.1182/blood-2023-184537
Published: 2023
Journal Articles

A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma

Free
Clinical Trials & Observations
Di Wang, Jue Wang, Guang Hu, Wen Wang, Yi Xiao, Haodong Cai, Lijun Jiang, Li Meng, Yongkun Yang, Xiaoxi Zhou, Zhenya Hong, Zheng Yao, Min Xiao, Liting Chen, Xia Mao, Li Zhu, Jin Wang, Lugui Qiu, Chunrui Li, Jianfeng Zhou
Journal: Blood
Blood (2021) 137 (21): 2890–2901.
https://doi.org/10.1182/blood.2020008936
Published: 2021
Includes: Supplemental data
Journal Articles

Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies

Free
Clinical Trials & Observations
Na Wang, Xuelian Hu, Wenyue Cao, Chunrui Li, Yi Xiao, Yang Cao, Chaojiang Gu, Shangkun Zhang, Liting Chen, Jiali Cheng, Gaoxiang Wang, Xiaoxi Zhou, Miao Zheng, Xia Mao, Lijun Jiang, Di Wang, Qiuxiang Wang, Yaoyao Lou, Haodong Cai, Dandan Yan, Yicheng Zhang, Tongcun Zhang, Jianfeng Zhou, Liang Huang
Journal: Blood
Blood (2020) 135 (1): 17–27.
https://doi.org/10.1182/blood.2019000017
Published: 2020
Includes: Supplemental data
Journal Articles

Efficacy and Safety of Fully Human Bcma Targeting CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma

Free
Chunrui Li, MD PhD, Jue Wang, MD PhD, Di Wang, MD PhD, Guang Hu, Yongkun Yang, Xiaoxi Zhou, MD PhD, Li Meng, MD PhD, Zhenya Hong, MD PhD, Liting Chen, PhD, Xia Mao, MD PhD, Min Xiao, MD PhD, Jianfeng Zhou, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 929.
https://doi.org/10.1182/blood-2019-128468
Published: 2019
Journal Articles

T Cells Expressing Anti B-Cell Maturation Antigen Chimeric Antigen Receptors for Plasma Cell Malignancies

Free
Chunrui Li, Qiuxiang Wang, Hui Zhu, Xia Mao, Ying Wang, MD, Yicheng Zhang, MDPhD, Jianfeng Zhou, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1013.
https://doi.org/10.1182/blood-2018-99-116898
Published: 2018